Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Price

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementiaD A Rottenberg, J J Sidtis, S C Strother, et al.
Journal of Medicinal Chemistry|August 1, 1988
Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracilJ Matulic-Adamic, K Takahashi, T C Chou, et al.
Annals of Neurology|December 1, 1987
The metabolic pathology of the AIDS dementia complexD A Rottenberg, J R Moeller, S C Strother, et al.
AIDS (London, England)|June 27, 2001
Cerebrospinal fluid response to structured treatment interruption after virological failureR W Price, E E Paxinos, R M Grant, et al.
Journal of Virology|April 1, 1992
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivoP Westervelt, D B Trowbridge, L G Epstein, et al.
Antiviral Research|December 1, 1988
Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cellsX B Kong, A C Scheck, R W Price, et al.
Journal of Neuroimmunology|September 1, 1992
Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patientsM P Heyes, B J Brew, K Saito, et al.
AIDS (London, England)|October 6, 1999
Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study teamR W Price, C T Yiannoutsos, D B Clifford, et al.
Neurology|February 1, 1991
HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipientJ E Kaplan, B Litchfield, C Rouault, et al.
Annals of Neurology|April 1, 1993
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials GroupJ J Sidtis, C Gatsonis, R W Price, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementiaD A Rottenberg, J J Sidtis, S C Strother, et al.
Journal of Medicinal Chemistry|August 1, 1988
Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracilJ Matulic-Adamic, K Takahashi, T C Chou, et al.
Annals of Neurology|December 1, 1987
The metabolic pathology of the AIDS dementia complexD A Rottenberg, J R Moeller, S C Strother, et al.
AIDS (London, England)|June 27, 2001
Cerebrospinal fluid response to structured treatment interruption after virological failureR W Price, E E Paxinos, R M Grant, et al.
Journal of Virology|April 1, 1992
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivoP Westervelt, D B Trowbridge, L G Epstein, et al.
Antiviral Research|December 1, 1988
Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cellsX B Kong, A C Scheck, R W Price, et al.
Journal of Neuroimmunology|September 1, 1992
Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patientsM P Heyes, B J Brew, K Saito, et al.
AIDS (London, England)|October 6, 1999
Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study teamR W Price, C T Yiannoutsos, D B Clifford, et al.
Neurology|February 1, 1991
HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipientJ E Kaplan, B Litchfield, C Rouault, et al.
Annals of Neurology|April 1, 1993
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials GroupJ J Sidtis, C Gatsonis, R W Price, et al.
Pageof 12